Literature DB >> 12392232

Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: a case study.

Fletcher Taylor1, Larry Cahill.   

Abstract

This case report concerns a 44-year-old woman who experienced 5 similar motor vehicle accidents, the last 3 causing severe PTSD episodes of over 6 months each, despite multiple pharmacotherapies. Following a 6th accident, severe PTSD symptoms reemerged. Forty-eight hours after this trauma, propranolol (60 mg) orally, twice a day (1.75 mg/kg/day) was begun, and the PTSD symptoms were rapidly and markedly reduced. The Clinician-Administered PTSD Rating Scale score was reduced from an initial 86 to 56 by 11 days posttrauma. To our knowledge, this is the first report of the effects of propranolol treatment on reemergent PTSD symptoms. Propranolol may be particularly efficacious in the prevention of initial or reemergent PTSD symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12392232     DOI: 10.1023/A:1020145610914

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  11 in total

1.  Psychosocial Response to Mass Casualty Terrorism: Guidelines for Physicians.

Authors:  Jeffrey C Fetter
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

2.  Prophylactic Ketamine Attenuates Learned Fear.

Authors:  Josephine C McGowan; Christina T LaGamma; Sean C Lim; Melina Tsitsiklis; Yuval Neria; Rebecca A Brachman; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2017-01-27       Impact factor: 7.853

Review 3.  Emotional memory function, personality structure and psychopathology: a neural system approach to the identification of vulnerability markers.

Authors:  Brian W Haas; Turhan Canli
Journal:  Brain Res Rev       Date:  2008-02-20

4.  Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.

Authors:  Danielle C Orrey; Omar I Halawa; Andrey V Bortsov; Jeffrey W Shupp; Samuel W Jones; Linwood R Haith; Janelle M Hoskins; Marion H Jordan; Shrikant I Bangdiwala; Brandon R Roane; Timothy F Platts-Mills; James H Holmes; James Hwang; Bruce A Cairns; Samuel A McLean
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

5.  Acute episodes of predator exposure in conjunction with chronic social instability as an animal model of post-traumatic stress disorder.

Authors:  Phillip R Zoladz; Cheryl D Conrad; Monika Fleshner; David M Diamond
Journal:  Stress       Date:  2008-07       Impact factor: 3.493

6.  Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.

Authors:  Yanfeng Wang; Zhijun Wang; Zhong Zuo; Brian Tomlinson; Benjamin T K Lee; Michael B Bolger; Moses S S Chow
Journal:  AAPS J       Date:  2013-04-19       Impact factor: 4.009

Review 7.  An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Biol Psychiatry       Date:  2015-06-15       Impact factor: 13.382

Review 8.  Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.

Authors:  John H Krystal; David F Tolin; Gerard Sanacora; Stacy A Castner; Graham V Williams; Deane E Aikins; Ralph E Hoffman; D Cyril D'Souza
Journal:  Drug Discov Today       Date:  2009-05-19       Impact factor: 7.851

9.  The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment.

Authors:  Dennis S Charney
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

10.  Modulation of PARP-1 Activity in a Broad Time Window Attenuates Memorizing Fear.

Authors:  Einat Elharrar; Yahav Dikshtein; Sapir Meninger-Mordechay; Yehuda Lichtenstein; Gal Yadid
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.